Trial on Innovative Technologies in Colonoscopy
Launched by JAGIELLONIAN UNIVERSITY · Sep 19, 2012
Trial Information
Current as of July 22, 2025
Completed
Keywords
ClinConnect Summary
A total of 600 consecutive patients undergoing screening unsedated colonoscopy will be randomly assigned to innovative or conventional examination. Randomization will be based on computer-generated randomization lists. All patients will be blinded so they will not know which techniques will be used to assess lesions found in colon. In innovative colonoscopy group narrow band imaging (NBI) and Dual Focus (DF) function will be used to identify and classify all lesions acc. to Sano and Kudo classification. Endoscopic biopsy will be taken from all lesion and endoscopic diagnosis will be compare...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • written informed consent
- • no previous abdominal surgery
- • no colonoscopy during last 10 years
- Exclusion Criteria:
- • age \< 40 and \> 65 years
- • large bowel resection in history
- • colonoscopy performed during last 10 years
- • contraindications for general anaesthesia
- • ASA \> IV
- • pregnancy
- • confirmed neoplastic disease
- • cirrhosis (Child B or C) or ascites
- • immunosuppressive therapy or steroids intake
- • malabsorption syndrome
About Jagiellonian University
Jagiellonian University, one of the oldest and most prestigious institutions of higher education in Poland, is a leading sponsor of clinical trials dedicated to advancing medical research and healthcare innovation. With a strong commitment to scientific excellence, the university leverages its extensive resources, multidisciplinary expertise, and collaborative network to conduct rigorous clinical studies that contribute to the development of new therapies and treatment strategies. Jagiellonian University emphasizes ethical research practices and strives to enhance patient outcomes through evidence-based findings, making significant contributions to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Krakow, Malopolska, Poland
Krakow, Malopolska, Poland
Patients applied
Trial Officials
Miroslaw Szura, MD, PhD
Principal Investigator
I Department of General Surgery, Jagiellonian University
Radoslaw Pach, MD, PhD
Study Chair
I Department of General Surgery, Jagiellonian University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials